Lucinda H. Stebbins is Director at TEKLA HEALTHCARE INVESTORS (HQH). They have made 9 open-market trades across 4 companies since 2006, most recently 2021-04-06.
CIK 0001236462
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $289K since 2006, against 1 sale. Across 8 scored buys the stock is down 1.2% at ninety days, and 2.5 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 13% | 13% |
| Avg Move | -15.4% | -1.8% | -1.2% |
| Alpha | -10.2% | -2.2% | -2.5% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| THW | BUY | 2021-02-19 | 2021-02-23 | $16.80 | $13K | -10.2% | -11.6% | -6.5% |
| HQH | BUY | 2015-06-29 | 2015-06-29 | $35.74 | $71K | -17.1% | -0.9% | -0.9% |
| HQL | BUY | 2015-06-29 | 2015-06-29 | $28.17 | $28K | -17.3% | -0.3% | -0.3% |
| THQ | BUY | 2014-12-03 | 2014-12-04 | $20.07 | $20K | -9.7% | +0.5% | +0.5% |
| HQH | BUY | 2009-09-03 | 2009-09-11 | $10.51 | $11K | -17.1% | -0.9% | -0.9% |
| HQL | BUY | 2009-05-18 | 2009-05-19 | $8.14 | $12K | -17.3% | -0.3% | -0.3% |
| HQL | BUY | 2008-02-25 | 2008-02-27 | $12.65 | $23K | -17.3% | -0.3% | -0.3% |
| HQL | SELL | 2007-12-31 | 2008-01-02 | $13.12 | $26K | -17.3% | -0.3% | -0.3% |
| HQH | BUY | 2007-08-21 | 2007-08-22 | $16.63 | $17K | -17.1% | -0.9% | -0.9% |
| HQL | BUY | 2007-02-09 | 2007-02-12 | $14.98 | $45K | -17.3% | -0.3% | -0.3% |
| HQH | BUY | 2006-12-27 | 2006-12-27 | $16.41 | $49K | -17.1% | -0.9% | -0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.